Activity of JC virus archetype and PML-type regulatory regions in glial cells.

References

1. Ahmed S., Rappaport J., Tada H., Kerr D., Khalili K. 1990; A nuclear protein derived from brain cells stimulates transcription of the human neurotropic virus promoter, JCVE, in vitro. Journal of Biological Chemistry 265:13899–13905
   [Google Scholar]
2. Amemiya K., Traub R., Durham L., Major E. O. 1989; Interaction of a nuclear factor-1-like protein with the regulatory region of the human polyomavirus JC virus. Journal of Biological Chemistry 264:7025–7032
   [Google Scholar]
3. Arthur R. R., Shah K. V. 1989; Occurrence and significance of papovaviruses BK and JC in the urine. Progress in Medical Virology 36:42–61
   [Google Scholar]
4. Atwood W. J., Amemiya K., Traub R., Harms J., Major E. O. 1992; Interaction of the human polyomavirus, JCV, with human B-lymphocytes. Virology 190:716–723
   [Google Scholar]
5. Atwood W. J., Wang L., Durham L. C., Amemiya K., Traub R. G., Major E. O. 1995; Evaluation of the role of cytokine activation in the multiplication of JC virus (JCV) in human fetal glial cells. Journal of Neurovirology 1:40–49
   [Google Scholar]
6. Ault G. S., Stoner G. L. 1992; Two major types of JC virus defined in progressive multifocal leukoencephalopathy brain by early and late coding region DNA sequences. Journal of General Virology 73:2669–2678
   [Google Scholar]
7. Ault G. S., Stoner G. L. 1993; Human polyomavirus JC promoter/ enhancer rearrangement patterns from progressive multifocal leuko-encephalopathy brain are unique derivatives of a single archetypal structure. Journal of General Virology 74:1499–1507
   [Google Scholar]
8. Ault G. S., Stoner G. L. 1994; Brain and kidney of progressive multifocal leukoencephalopathy patients contain identical rearrangements of the JC virus promoter/enhancer. Journal of Medical Virology 44:298–304
   [Google Scholar]
9. Cassill J. A., Subramani S. 1989; A naturally occurring deletion in the enhancer repeats of the human papovavirus BK optimizes early enhancer function at the expense of late promoter activity. Virology 170:296–298
   [Google Scholar]
10. Chowdhury M., Kundu M., Khalili K. 1993; GA/GC-rich sequence confers Tat responsiveness to human neurotropic virus promoter, JCVL, in cells derived from central nervous system. Oncogene 8:887–892
    [Google Scholar]
11. Coleman D. V., Wolfendale M. R., Daniel R. A., Dhanjal N. K., Gardner S. D., Gibson P. E., Field A. M. 1980; A prospective study of human polyomavirus infection in pregnancy. Journal of Infectious Diseases 142:1–8
    [Google Scholar]
12. Daniel A. M., Swenson J. J., Mayreddy R. P. R., Khalili K., Frisque R. J. 1996; Sequences within the early and late promoters of archetype JC virus restrict viral DNA replication and infectivity. Virology 216:90–101
    [Google Scholar]
13. Daniel A. M., Frisque R. J. 1993; Transcription initiation sites of prototype and variant JC virus early and late messenger RNAs. Virology 194:97–109
    [Google Scholar]
14. Feigenbaum L., Khalili K., Major E. O., Khoury G. 1987; Regulation ofthe host range ofhuman papovavirus JCV. Proceedings ofthe National Academy of Sciences, USA 84:3695–3698
    [Google Scholar]
15. Flaegstad T., Sundsfjord A., Arthur R. R., Pedersen M., Traavik T., Subramani S. 1991; Amplification and sequencing of the control regions of BK and JC virus from human urine by polymerase chain reaction. Virology 180:553–560
    [Google Scholar]
16. Frisque R. J., Bream G. L., Cannella M. T. 1984; Human polyomavirus JC virus genome. Journal of Virology 51:458–469
    [Google Scholar]
17. Frisque R. J., White F. A. III 1992; The molecular biology of JC virus, causative agent of progressive multifocal leukoencephalopathy. In Neurovirology - Pathogenesis of Viral CNS Infections pp. 25–158 Roos R. P., Totowa N. J. Edited by New York: Humana;
    [Google Scholar]
18. Heilbronn R., Albrecht I., Stephan S., Burkle A., zur Hausen H. 1993; Human cytomegalovirus induces JC virus DNA replication in human fibroblasts. Proceedings ofthe National Academy of Sciences, USA 90:11406–11410
    [Google Scholar]
19. Henson J., Saffer J., Furneaux H. 1992; The transcription factor Sp1 binds to the JC virus promoter and is selectively expressed in glial cells in human brain. Annals of Neurology 32:72–77
    [Google Scholar]
20. Hirt B. 1967; Selective extraction of polyoma DNA from infected mouse cell cultures. Journal of Molecular Biology 26:365–369
    [Google Scholar]
21. Hogan T. F., Padgett B. L., Walker D. L. 1991; Human polyoma- viruses. In Textbook of Human Virology pp. 970–1000 Belshe R. B. Edited by St Louis: Mosby;
    [Google Scholar]
22. Houff S. A., Major E. O., Katz D. A., Kufta C. V., Sever J. L., Pittaluga S., Roberts J. R., Gitt J., Saini N., Lux W. 1988; Involvement of JC virus-infected mononuclear cells from the bone marrow and spleen in the pathogenesis of progressive multifocal leukoencephalopathy. New England Journal of Medicine 318:301–305
    [Google Scholar]
23. Iida T., Kitamura T., Guo J., Taguchi F., Aso Y., Nagashima K., Yogo Y. 1993; Origin of JC polyomavirus variants associated with progressive multifocal leukoencephalopathy. Proceedings of the National Academy of Sciences, USA 90:5062–5065
    [Google Scholar]
24. Kenney S., Natarajan V., Strike D., Khoury G., Salzman N. P. 1984; JC virus enhancer-promoter active in human brain cells. Science 226:1337–1339
    [Google Scholar]
25. Kenney S., Natarajan V., Salzman N. P. 1986; Mapping 5′ termini of JC virus late RNA. Journal of Virology 58:216–219
    [Google Scholar]
26. Kitamura T., Aso Y., Kuniyoshi N., Hara K., Yogo Y. 1990; High incidence of urinary JC virus excretion in nonimmunosuppressed older patients. Journal of Infectious Diseases 161:1128–1133
    [Google Scholar]
27. Kitamura T., Yogo Y., Kunitake T., Suzuki K., Tajima A., Kawabe K. 1994; Effect of immunosuppression on the urinary excretion of BK and JC polyomaviruses in renal allograft recipients. International Journal of Urology 1:28–32
    [Google Scholar]
28. Krebs C. J., McAvoy M. T., Kumar G. 1995; The JC virus minimal core promoter is glial cell specific in vivo. Journal of Virology 69:2434–2442
    [Google Scholar]
29. Lashgari M. S., Tada H., Amini S., Khalili K. 1989; Regulation of JCVL promoter function: transactivation of JCVL promoter by JCV and SV40 early proteins. Virology 170:292–295
    [Google Scholar]
30. Loeber G., Dörries K. 1988; DNA rearrangements in organ-specific variants of polyomavirus JC strain GS. Journal of Virology 62:1730–1735
    [Google Scholar]
31. Lynch K. J., Frisque R. J. 1990; Identification of critical elements within the JC virus DNA replication origin. Journal of Virology 64:5812–5822
    [Google Scholar]
32. Major E. O., Ault G. S. 1995; Progressive multifocal leuko- encephalopathy: clinical and laboratory observations on a viral induced demyelinating disease in the immunodeficient patient. Current Opinion in Neurology 8:184–190
    [Google Scholar]
33. Markowitz R. B., Eaton B. A., Kubik M. F., Latorra D., McGregor J. A., Dynan W. S. 1991; BK virus and JC virus shed during pregnancy have predominantly archetypal regulatory regions. Journal of Virology 65:4515–4519
    [Google Scholar]
34. Markowitz R. B., Thompson H. C., Mueller J. F., Cohen J. A., Dynan W. S. 1993; Incidence of BK virus and JC virus viruria in human immunodeficiency virus-infected and -uninfected subjects. Journal of Infectious Diseases 167:13–20
    [Google Scholar]
35. Nakshatri H., Pater A., Pater M. M. 1990; Activity and enhancer binding factors for JC virus regulatory elements in differentiating embryonal carcinoma cells. Virology 177:784–789
    [Google Scholar]
36. Padgett B. L., Walker D. L. 1973; Prevalence of antibodies in human sera against JC virus, an isolate of progressive multifocal leukoencephalopathy. Journal of Infectious Diseases 127:467–470
    [Google Scholar]
37. Raj G. V., Khalili K. 1995; Transcriptional regulation: lessons from the human neurotropic polyomavirus, JCV. Virology 213:283–291
    [Google Scholar]
38. Renner K., Leger H., Wegner M. 1994; The POU domain protein Tst-1 and papovaviral large tumor antigen function synergistically to stimulate glia-specific gene expression of JC virus. Proceedings of the National Academy of Sciences, USA 91:6433–6437
    [Google Scholar]
39. Sock E., Wegner M., Grummt F. 1991; DNA replication of human polyomavirus JC is stimulated by NF-I in vivo. Virology 182:298–308
    [Google Scholar]
40. Sock E., Wegner M., Fortunato E. A., Grummt F. 1993; Large T-antigen and sequences within the regulatory region of JC virus both contribute to the features of JC virus DNA replication. Virology 197:537–548
    [Google Scholar]
41. Sock E., Renner K., Feist D., Leger H., Wegner M. 1996; Functional comparison of PML-type and archetype strains of JC virus. Journal of Virology 70:1512–1520
    [Google Scholar]
42. Tada H., Lashgari M. S., Rappaport J., Khalili K. 1989; Cell type- specific expression of JC virus early promoter is determined by positive and negative regulation. Journal of Virology 63:463–466
    [Google Scholar]
43. Tada H., Rappaport J., Lashgari M. S., Amini S., Wong-Staal F., Khalili K. 1990; Trans-activation of the JC virus late promoter by the tat protein of type 1 human immunodeficiency virus in glial cells. Proceedings of the National Academy of Sciences, USA 87:3479–3483
    [Google Scholar]
44. Tamura T., Inoue T., Nagata K., Mikoshiba K. 1988; Enhancer of human polyoma JC virus contains nuclear factor I-binding sequences; analysis using mouse brain nuclear extracts. Biochemical and Biophysical Research Communications 157:419–425
    [Google Scholar]
45. Tominaga T., Yogo Y., Kitamura T., Aso Y. 1992; Persistence of archetypal JC virus DNA in normal renal tissue derived from tumorbearing patients. Virology 186:736–741
    [Google Scholar]
46. Tornatore C., Berger J. R., Houff S. A., Curfman B., Meyers K., Winfield D., Major E. O. 1992; Detection of JC virus DNA in peripheral lymphocytes from patients with and without progressive multifocal leukoencephalopathy. Annals of Neurology 31:454–462
    [Google Scholar]
47. Tornatore C., Amemiya K., Atwood W. J., Conant K., Major E. O. 1994; JC virus : current concepts and controversies in the molecular virology and pathogenesis of progressive multifocal leukoencephalo- pathy. Reviews in Medical Virology 4:197–219
    [Google Scholar]
48. Wegner M., Drolet D. W., Rosenfeld M. G. 1993; Regulation of JC virus by the POU-domain transcription factor Tst-1 : implications for progressive multifocal leukoencephalopathy. Proceedings of the National Academy of Sciences, USA 90:4743–4747
    [Google Scholar]
49. Yogo Y., Kitamura T., Sugimoto C., Ueki T., Aso Y., Hara K., Taguchi F. 1990; Isolation of a possible archetypal JC virus DNA sequence from nonimmunocompromised individuals. Journal of Virology 64:3139–3143
    [Google Scholar]
50. Yogo Y., Guo J., Iida T., Satoh K.-I., Taguchi F., Takahashi H., Hall W. W., Nagashima K. 1994; Occurrence of multiple JC virus variants with distinctive regulatory sequences in the brain of a single patient with progressive multifocal leukoencephalopathy. Virus Genes 8:99–105
    [Google Scholar]